FDA Sounds the Alarm on Compounded Topical Finasteride: What You Need to Know and Safer Alternatives
In April 2025, the U.S. Food and Drug Administration (FDA) issued a public alert concerning compounded topical finasteride products, commonly used to treat hair loss. While oral finasteride (marketed as Propecia and Proscar) is FDA-approved, its topical counterparts are not. The agency has received reports of adverse events associated with these unapproved topical formulations, prompting this warning.